BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hachem RR, Yusen RD, Chakinala MM, Aloush AA, Patterson GA, Trulock EP. Thrombotic Microangiopathy after Lung Transplantation. Transplantation 2006;81:57-63. [DOI: 10.1097/01.tp.0000188140.50673.63] [Cited by in Crossref: 24] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Verbiest A, Pirenne J, Dierickx D. De novo thrombotic microangiopathy after non-renal solid organ transplantation. Blood Reviews 2014;28:269-79. [DOI: 10.1016/j.blre.2014.09.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
2 Barry M, Chandra S, Hymes KB. Cytopenias in Transplant Patients. In: Safdar A, editor. Principles and Practice of Transplant Infectious Diseases. New York: Springer; 2019. pp. 199-207. [DOI: 10.1007/978-1-4939-9034-4_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
3 Rosove MH. Thrombotic microangiopathies. Seminars in Arthritis and Rheumatism 2014;43:797-805. [DOI: 10.1016/j.semarthrit.2013.11.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
4 Manière L, Domenger C, Camara B, Giovannini D, Malvezzi P, Rostaing L. An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient. Case Rep Transplant 2019;2019:9465040. [PMID: 31110835 DOI: 10.1155/2019/9465040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Rossi AP, Vella JP. Acute Kidney Disease After Liver and Heart Transplantation. Transplantation 2016;100:506-14. [PMID: 26502368 DOI: 10.1097/TP.0000000000000916] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Schwarz S, Jaksch P, Klepetko W, Hoetzenecker K. Immunosuppression after lung transplantation: the search for the holy grail continues. J Thorac Dis 2017;9:1412-4. [PMID: 28740645 DOI: 10.21037/jtd.2017.04.66] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Neuringer IP, Noone P, Cicale RK, Davis K, Aris RM. Managing complications following lung transplantation. Expert Rev Respir Med 2009;3:403-23. [PMID: 20477331 DOI: 10.1586/ers.09.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
8 Dierich M, Fuehner T, Welte T, Simon A, Gottlieb J. [Lung transplantation. Indications, long-term results and special impact of follow-up care]. Internist (Berl) 2009;50:561-71. [PMID: 19436963 DOI: 10.1007/s00108-008-2271-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kotecha S, Ivulich S, Snell G. Review: immunosuppression for the lung transplant patient. J Thorac Dis 2021;13:6628-44. [PMID: 34992841 DOI: 10.21037/jtd-2021-11] [Reference Citation Analysis]
10 Dako F, Hota P, Kahn M, Kumaran M, Agosto O. Post-lung transplantation abdominopelvic complications: the role of multimodal imaging. Abdom Radiol (NY) 2020;45:1202-13. [PMID: 31552464 DOI: 10.1007/s00261-019-02229-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Smith EP. Hematologic Disorders after Solid Organ Transplantation. Hematology 2010;2010:281-6. [DOI: 10.1182/asheducation-2010.1.281] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
12 Nava F, Cappelli G, Mori G, Granito M, Magnoni G, Botta C, Solazzo A, Fontana F, Baisi A, Bonucchi D. Everolimus, cyclosporine, and thrombotic microangiopathy: clinical role and preventive tools in renal transplantation. Transplant Proc. 2014;46:2263-2268. [PMID: 25242766 DOI: 10.1016/j.transproceed.2014.07.062] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
13 Hershko K, Simhadri VL, Blaisdell A, Hunt RC, Newell J, Tseng SC, Hershko AY, Choi JW, Sauna ZE, Wu A, Bram RJ, Komar AA, Kimchi-Sarfaty C. Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat). J Biol Chem 2012;287:44361-71. [PMID: 23144461 DOI: 10.1074/jbc.M112.383968] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
14 Fuehner T, Greer M, Welte T, Gottlieb J. The lung transplant patient in the ICU: . Current Opinion in Critical Care 2012;18:472-8. [DOI: 10.1097/mcc.0b013e328356d982] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
15 Menezes MDM, Aires I, Semedo L, Calado J, Ribeiro F, Nolasco F. An Atypical Presentation of Thrombotic Microangiopathy After Lung Transplant: A Case Report. Transplant Proc 2019;51:1633-5. [PMID: 31155208 DOI: 10.1016/j.transproceed.2019.05.002] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Nishi H, Hanafusa N, Kondo Y, Nangaku M, Sugawara Y, Makuuchi M, Noiri E, Fujita T. Clinical Outcome of Thrombotic Microangiopathy after Living-Donor Liver Transplantation Treated with Plasma Exchange Therapy. CJASN 2006;1:811-9. [DOI: 10.2215/cjn.01781105] [Cited by in Crossref: 17] [Cited by in F6Publishing: 2] [Article Influence: 1.1] [Reference Citation Analysis]